Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening

Gynecologic Oncology

Volumn 139, Issue 2, 2015, Pages 211-215

  Frey, Melissa K ^a   Kim, Sarah H ^a   Bassett, Rebecca Yee ^a   Martineau, Jessica ^a   Dalton, Emily ^b   Chern, Jing Yi ^a   Blank, Stephanie V ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b AMBRY GENETICS   (United States)

Author keywords

Multi gene panel testing; Ovarian cancer; Single gene testing

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; RAD50 PROTEIN; RAD51 PROTEIN; SMAD4 PROTEIN; ADENOSINE TRIPHOSPHATASE; CADHERIN; CDH1 PROTEIN, HUMAN; DNA BINDING PROTEIN; DNA LIGASE; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; RAD51D PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; BRAIN CANCER; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD; MELANOMA; MISMATCH REPAIR; MULTI GENE PANEL TESTING; NEXT GENERATION SEQUENCING; NON INFORMATIVE GENETIC SCREENING; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RESCREENING; STOMACH CANCER; AGED; BREAST NEOPLASMS; COHORT ANALYSIS; COLONIC NEOPLASMS; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; OVARIAN NEOPLASMS; PROCEDURES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TUMOR SUPPRESSOR GENE; UTERUS CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; BREAST NEOPLASMS; CADHERINS; COHORT STUDIES; COLONIC NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA2; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 84952630873     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.08.006     Document Type: Article

References (23)

1. S.M. Domchek, and K.L. Nathanson Panel testing for inherited susceptibility to breast, ovarian, and colorectal cancer Genet. Med. 16 11 2014 827 829
2. C.S. Walsh Two decades beyond BRCA1/2: homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy Gynecol. Oncol. 137 2 2015 343 350
3. L.E. Minion, J.S. Dolinsky, D.M. Chase, C.L. Dunlop, E.C. Chao, and B.J. Monk Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2 Gynecol. Oncol. 137 1 2015 86 92
4. T. Walsh, S. Casadei, M.K. Lee, C.C. Pennil, A.S. Nord, A.M. Thornton, and et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing Proc. Natl. Acad. Sci. U. S. A. 108 2011 18032 18037
5. K.P. Pennington, and E.M. Swisher Hereditary ovarian cancer: beyond the usual suspects Gynecol. Oncol. 124 2012 347 353
6. S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, and et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet. Med. 17 2015 405 423
7. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, and et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
8. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, and et al. Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
9. A. Antoniou, P.D. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, and et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am. J. Hum. Genet. 72 2003 1117 1130
10. K. Alsop, S. Fereday, C. Meldrum, A. deFazio, C. Emmanuel, J. George, and et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group J. Clin. Oncol. 30 2012 2654 2663
11. F.J. Couch, S.N. Hart, P. Sharma, A.E. Toland, X. Wang, P. Miron, and et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer J. Clin. Oncol. 33 2015 304 311
12. T. Rafnar, D.F. Gudbjartsson, P. Sulem, A. Jonasdottir, A. Sigurdsson, A. Jonasdottir, and et al. Mutations in BRIP1 confer high risk of ovarian cancer Nat. Genet. 43 2011 1104 1107
13. C. Loveday, C. Turnbull, E. Ramsay, D. Hughes, E. Ruark, J.R. Frankum, and et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer Nat. Genet. 43 2011 879 882
14. A. Wickramanayake, G. Bernier, C. Pennil, S. Casadei, K.J. Agnew, S.M. Stray, and et al. Loss of function germline mutations in RAD51D in women with ovarian carcinoma Gynecol. Oncol. 127 2012 552 555
15. D.F. Easton Cancer risks in A-T heterozygotes Int. J. Radiat. Biol. 66 1994 S177 S182
16. D. Thompson, S. Duedal, J. Kirner, L. McGuffog, J. Last, A. Reiman, and et al. Cancer risks and mortality in heterozygous ATM mutation carriers J. Natl. Cancer Inst. 97 2005 813 822
17. A.K. Win, J.G. Dowty, S.P. Cleary, H. Kim, D.D. Buchanan, J.P. Young, and et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer Gastroenterology 146 2014 1208 1211 (e1-5)
18. G. Rennert, F. Lejbkowicz, I. Cohen, M. Pinchev, H.S. Rennert, and O. Barnett-Griness MutYH mutation carriers have increased breast cancer risk Cancer 118 2012 1989 1993
19. L. Petrukhin, J. Dangel, L. Vanderveer, J. Costalas, A. Bellacosa, G. Grana, and et al. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds Cancer Res. 57 1997 5480 5484
20. S.E. Plon, H.P. Cooper, B. Parks, S.U. Dhar, P.A. Kelly, A.D. Weinberg, and et al. Genetic testing and cancer risk management recommendations by physicians for at-risk relatives Genet. Med. 13 2011 148 154
21. E.B. Gomez Garcia, J.C. Oosterwijk, M. Timmermans, C.J. van Asperen, F.B. Hogervorst, N. Hoogerbrugge, and et al. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Breast Cancer Res. 11 2009 R8
22. J.L. Berliner, A.M. Fay Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest G Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors J. Genet. Couns. 16 2007 241 260
23. J.M. Eggington, K.R. Bowles, K. Moyes, S. Manley, L. Esterling, S. Sizemore, and et al. A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes Clin. Genet. 86 2014 229 237